Katherine Stueland - 26 Apr 2023 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role
Chief Executive Officer
Signature
/s/ Bridget Brown, Attorney-in-Fact
Issuer symbol
WGS
Transactions as of
26 Apr 2023
Net transactions value
$0
Form type
4
Filing time
27 Apr 2023, 19:41:39 UTC
Previous filing
13 Mar 2023
Next filing
02 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WGS Restricted Stock Unit Award $0 +9,900,000 $0.000000 9,900,000 26 Apr 2023 Class A Common Stock 9,900,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
F2 6.25% vest in quarterly installments over the four-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.